Contralateral risk reducing mastectomy in Non-BRCA-Mutated patients

The use of contralateral risk reducing mastectomy (CRRM) is indicated in women affected by breast cancer, who are at high risk of developing a contralateral breast cancer, particularly women with genetic mutation of BRCA1, BRCA2 and P53. However we should consider that the genes described above acco...

Descripción completa

Detalles Bibliográficos
Autores principales: Falco, Giuseppe, Rocco, Nicola, Bordoni, Daniele, Marano, Luigi, Accurso, Antonello, Buccelli, Claudio, Di Lorenzo, Pierpaolo, Capasso, Emanuele, Policino, Fabio, Niola, Massimo, Ferrari, Guglielmo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter Open 2016
Materias:
Focus on Medico-Legal and Ethical Topics in Surgery in Italy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329834/
https://www.ncbi.nlm.nih.gov/pubmed/28352801
http://dx.doi.org/10.1515/med-2016-0047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329834/
https://www.ncbi.nlm.nih.gov/pubmed/28352801
http://dx.doi.org/10.1515/med-2016-0047

Ejemplares similares